Search research articles
Contact Us
Filters
Showing results (271-280 of 283) with videos related to
Page
of 29
Sort By:
JACC. Cardiovascular Interventions
|
March 16, 2020
Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-III
Ariel Roguin, Rosaly A Buiten, Carine J M Doggen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
May 22, 2024
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials
Eline H Ploumen, Edimir Semedo, Carine J M Doggen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
March 11, 2021
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial
Eline H Ploumen, Rosaly A Buiten, Paolo Zocca, et al.
American Heart Journal
|
April 15, 2018
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial
Liefke C van der Heijden, Marlies M Kok, Paolo Zocca, et al.
Journal of the American Heart Association
|
January 12, 2024
Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk
Ran Kornowski, Maayan Konigstein, Michael Jonas, et al.
JACC. Cardiovascular Interventions
|
May 9, 2020
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years
Rosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
Lancet (London, England)
|
September 27, 2018
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial
Clemens von Birgelen, Paolo Zocca, Rosaly A Buiten, et al.
International Journal of Cardiology
|
November 5, 2020
Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials
Eline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
American Heart Journal
|
September 4, 2020
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials
Eline H Ploumen, Rosaly A Buiten, Carine J M Doggen, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
January 14, 2024
SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device
Daniel Kim, Jeremy D Collins, James A White, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 283) with videos related to
Sort By:
Page
of 29
JACC. Cardiovascular Interventions
|
March 16, 2020
Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-III
Ariel Roguin, Rosaly A Buiten, Carine J M Doggen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
May 22, 2024
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials
Eline H Ploumen, Edimir Semedo, Carine J M Doggen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
March 11, 2021
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial
Eline H Ploumen, Rosaly A Buiten, Paolo Zocca, et al.
American Heart Journal
|
April 15, 2018
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial
Liefke C van der Heijden, Marlies M Kok, Paolo Zocca, et al.
Journal of the American Heart Association
|
January 12, 2024
Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk
Ran Kornowski, Maayan Konigstein, Michael Jonas, et al.
JACC. Cardiovascular Interventions
|
May 9, 2020
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years
Rosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
Lancet (London, England)
|
September 27, 2018
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial
Clemens von Birgelen, Paolo Zocca, Rosaly A Buiten, et al.
International Journal of Cardiology
|
November 5, 2020
Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials
Eline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
American Heart Journal
|
September 4, 2020
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials
Eline H Ploumen, Rosaly A Buiten, Carine J M Doggen, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
January 14, 2024
SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device
Daniel Kim, Jeremy D Collins, James A White, et al.
Page
of 29